NASDAQ:PASG | Cash Flow Statement | Passage BIO, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$7.82M
2026-03-31-$7.56M$129,000.00-$12.99M$20,000.00
2025-12-31-$12.98M$177,000.00-$6.48M$0.00$9,000.00
2025-09-30-$7.75M$200,000.00
2025-06-30-$9.39M$200,000.00
2025-03-31-$15.41M$201,000.00-$13.85M$39.63M
2024-12-31-$12.73M$719,000.00-$8.44M$13.68M$47,000.00
2024-09-30-$19.34M$800,000.00
2024-06-30-$15.99M$800,000.00
2024-03-31-$16.71M$806,000.00-$18.93M$25.25M$8.74M
2023-12-31-$16.76M$807,000.00-$19.52M$7.6M$46,000.00
2023-09-30-$27.11M$1M
2023-06-30-$23.86M$1M
2023-03-31-$34.34M$978,000.00-$22.45M$21.22M
2022-12-31-$27.07M$946,000.00-$24.02M-$3.36M-$588,000.00
2022-09-30-$26.7M$900,000.00
2022-06-30-$39.54M$900,000.00
2022-03-31-$42.81M$883,000.00-$44.71M$17.31M$49,000.00
2021-12-31-$51.15M$669,000.00-$30.78M-$3.61M$455,000.00
2021-09-30-$46.92M
2021-06-30-$48.44M
2021-03-31-$38.88M$211,000.00-$30.72M-$20.4M$165.63M
2020-12-31-$38.94M$278,000.00-$29.42M-$36.55M$402,000.00
2020-09-30-$28.53M
2020-06-30-$27.17M
2020-03-31-$17.59M$49,000.00-$21.85M-$99,000.00$229.9M
2019-12-31-$13.15M$45,000.00-$17.48M-$43,000.00-$799,000.00
2019-09-30-$11.39M
2019-06-30-$13.43M
2019-03-31-$7.67M$12,000.00-$214,000.00-$884,000.00$20.16M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$45.52M$728,000.00-$31.51M$40.22M$23,000.00
2024-12-31-$64.77M$3.08M-$47.96M$54.95M$8.87M
2023-12-31-$102.06M$3.72M-$78.26M$65.24M$135,000.00
2022-12-31-$136.13M$3.68M-$118.21M$25.2M-$1.35M
2021-12-31-$185.39M$1.54M-$126.88M-$45.81M$166.66M
2020-12-31-$112.23M$800,000.00-$80.52M-$172.11M$228.75M
2019-12-31-$45.63M$134,000.00-$39.9M-$1.69M$175.6M